C
Crystal Cooper
Researcher at University of Texas Southwestern Medical Center
Publications - 52
Citations - 2433
Crystal Cooper is an academic researcher from University of Texas Southwestern Medical Center. The author has contributed to research in topics: Major depressive disorder & Sertraline. The author has an hindex of 19, co-authored 50 publications receiving 1426 citations. Previous affiliations of Crystal Cooper include University of Pittsburgh & University of Texas at Arlington.
Papers
More filters
Journal ArticleDOI
Harmonization of cortical thickness measurements across scanners and sites.
Jean-Philippe Fortin,Nicholas C. Cullen,Yvette I. Sheline,Warren D. Taylor,Irem Aselcioglu,Philip A. Cook,Phil Adams,Crystal Cooper,Maurizio Fava,Patrick J. McGrath,Melvin G. McInnis,Mary L. Phillips,Madhukar H. Trivedi,Myrna M. Weissman,Russell T. Shinohara +14 more
TL;DR: It is shown that ComBat removes unwanted sources of scan variability while simultaneously increasing the power and reproducibility of subsequent statistical analyses, and is useful for combining imaging data with the goal of studying life‐span trajectories in the brain.
Journal ArticleDOI
Establishing moderators and biosignatures of antidepressant response in clinical care (EMBARC): Rationale and design.
Madhukar H. Trivedi,Patrick J. McGrath,Maurizio Fava,Ramin V. Parsey,Benji T. Kurian,Mary L. Phillips,Maria A. Oquendo,Gerard E. Bruder,Diego A. Pizzagalli,Marisa Toups,Crystal Cooper,Phil Adams,Sarah Weyandt,David W. Morris,Bruce D. Grannemann,R. Todd Ogden,Randy L. Buckner,Melvin G. McInnis,Helena C. Kraemer,Eva Petkova,Thomas J. Carmody,Myrna M. Weissman +21 more
TL;DR: The study is designed to standardize assessment of biomarkers across multiple sites as well as institute replicable quality control methods, and to use advanced data analytic methods to integrate these markers.
Journal ArticleDOI
An electroencephalographic signature predicts antidepressant response in major depression
Wei Wu,Yu Zhang,Yu Zhang,Jing Jiang,Jing Jiang,Molly V. Lucas,Molly V. Lucas,Gregory A. Fonzo,Gregory A. Fonzo,Camarin E. Rolle,Camarin E. Rolle,Crystal Cooper,Cherise Chin-Fatt,Noralie Krepel,Carena A. Cornelssen,Carena A. Cornelssen,Rachael Wright,Rachael Wright,Russell T. Toll,Russell T. Toll,Hersh M. Trivedi,Hersh M. Trivedi,Karen Monuszko,Karen Monuszko,Trevor Caudle,Trevor Caudle,Kamron Sarhadi,Kamron Sarhadi,Manish K. Jha,Joseph M. Trombello,Thilo Deckersbach,Phil Adams,Patrick J. McGrath,Myrna M. Weissman,Maurizio Fava,Diego A. Pizzagalli,Martijn Arns,Madhukar H. Trivedi,Amit Etkin,Amit Etkin +39 more
TL;DR: A latent-space machine-learning algorithm tailored for resting-state electroencephalography (EEG) was designed and applied to data from the largest imaging-coupled, placebo-controlled antidepressant study and found that the efficacy of an antidepressant is predicted from an EEG signature.
Journal ArticleDOI
Test–retest reliability of freesurfer measurements within and between sites: Effects of visual approval process
Zafer Iscan,Tony B. Jin,Alexandria Kendrick,Bryan C. Szeglin,Hanzhang Lu,Madhukar H. Trivedi,Maurizio Fava,Patrick J. McGrath,Myrna M. Weissman,Benji T. Kurian,Phillip Adams,Sarah Weyandt,Marisa Toups,Thomas J. Carmody,Melvin G. McInnis,Cristina Cusin,Crystal Cooper,Maria A. Oquendo,Ramin V. Parsey,Christine DeLorenzo,Christine DeLorenzo +20 more
TL;DR: To determine the effect of visual inspection on sample size required for studies of MRI‐derived cortical thickness, the number of subjects required to show group differences was calculated and significant differences observed across imaging sites, between visually approved/disapproved subjects, and across regions with different sizes suggest that these measures should be used with caution.
Journal ArticleDOI
Pretreatment Rostral Anterior Cingulate Cortex Theta Activity in Relation to Symptom Improvement in Depression: A Randomized Clinical Trial
Diego A. Pizzagalli,Christian A. Webb,Daniel G. Dillon,Craig E. Tenke,Jürgen Kayser,Franziska Goer,Maurizio Fava,Patrick J. McGrath,Myrna M. Weissman,Ramin V. Parsey,Phil Adams,Joseph M. Trombello,Crystal Cooper,Patricia J. Deldin,Maria A. Oquendo,Melvin G. McInnis,Thomas J. Carmody,Gerard E. Bruder,Madhukar H. Trivedi +18 more
TL;DR: Increased pretreatment rACC theta activity represents a nonspecific prognostic marker of treatment outcome, and predicted greater depressive symptom improvement, even when controlling for clinical and demographic variables previously linked with treatment outcome.